postpartum hemorrhage
Jump to navigation
Jump to search
Etiology
- acquired coagulation factor inhibitors
- coagulation factor VIII autoantibody
- can appear in late pregnancy or early postpartum
- thrombotic thrombocytopenic purpura can appear late in pregnancy or after delivery.
- HELLP syndrome typically manifests before delivery, can appear after delivery
- immune thrombocytopenic purpura
- usually manifests by 3rd trimester
- acute fatty liver of pregnancy
- can manifest with thrombocytopenia;
- almost always develops before delivery, but diagnosis may be delayed because of a failure to recognize
Laboratory
- complete blood count (CBC)
- peripheral smear
- prothrombin time with INR & aPTT
- mixing studies if aPTT prolonged
- failure to correct with normal plasma 1:1 suggests coagulation factor inhibitor
- most likely coagulation factor VIII autoantibody[1]
- failure to correct with normal plasma 1:1 suggests coagulation factor inhibitor
- plasma fibrinogen, plasma D-dimer
Management
- recominant factor VIIa for coagulation factor VIII autoantibody[1]
- tranexamic acid (1 g as 10 mg/min intravenous infusion) reduces mortality[3]
- effectiveness of tranexamic acid decreases 10% for every 15-minute delay & is negligible at 3 hours[4]
More general terms
Additional terms
References
- ↑ 1.0 1.1 1.2 Medical Knowledge Self Assessment Program (MKSAP) 16, American College of Physicians, Philadelphia 2012
- ↑ Gibson CJ, Berliner N, Miller AL et al A Bruising Loss. N Engl J Med 2016; 375:76-81. July 7, 201 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27406351 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcps1500127
- ↑ 3.0 3.1 WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet 2017 Apr 26 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28456509 Free Article <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30638-4/fulltext
- ↑ 4.0 4.1 Gayet-Ageron A, Prieto-Merino D et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: A meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet 2017 Nov 7; [e-pub]. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29126600 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32455-8/fulltext
Dries DJ. Tranexamic acid: Is it about time? Lancet 2017 Nov 7 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29126598 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32806-4/fulltext